EFX
58
-7
F
48
-6
AA
41
-6
LOW
36
-13
CINF
51
-3
FTI
68
-16
SWKS
37
5
ROK
34
-2
CHD
54
-2
INTU
61
-5
TDC
28
-6
DAL
37
4
CMS
55
2
GD
49
-3
GWW
51
-9
SWK
28
-6
URBN
59
-3
LRCX
43
-6
NOV
45
-5
ZION
64
-3
EFX
58
-7
F
48
-6
AA
41
-6
LOW
36
-13
CINF
51
-3
FTI
68
-16
SWKS
37
5
ROK
34
-2
CHD
54
-2
INTU
61
-5
TDC
28
-6
DAL
37
4
CMS
55
2
GD
49
-3
GWW
51
-9
SWK
28
-6
URBN
59
-3
LRCX
43
-6
NOV
45
-5
ZION
64
-3
Financhill
Back

Astrana Health 10K Form

Sell
36

ASTH
Astrana Health

Last Price:
$30.5100
Seasonality Move:
11%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ASTH News And Ratings

See the #1 stock for the next 7 days that we like better than ASTH

ASTH Financial Statistics

Sales & Book Value

Annual Sales: $2B
Cash Flow: $-13.5M
Price / Cash Flow: 33.18
Annual Sales: $14.87
Price / Book: 1.94

Profitability

EPS (TTM): 0.89000
Net Income (TTM): $43.1M
Gross Margin: $271.4M
Return on Equity: 9.13%
Return on Assets: 3.57%

Astrana Health Earnings Forecast

Key Astrana Health Financial Ratios

  • The Gross Profit Margin over the past 16 years for ASTH is 13.34%.
  • The Selling, General & Administrative Expenses for ASTH have been equal to 7.57% of Gross Profit Margin.
  • The Interest Expense is 76.70% of Operating Income.
  • The Net Earning history of ASTH is 2.12% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 8 years.

Astrana Health Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: ASTH
Website: astranahealth.com

Debt

Debt-to-Equity Ratio: 0.61
Current Ratio: 1.75
Quick Ratio: 1.68

Price-to-Earnings

Trailing P/E Ratio: 33.93
Forward P/E Ratio: 13.45

ASTH Technical Analysis vs Fundamental Analysis

Sell
36
Astrana Health (ASTH) is a Sell

Is Astrana Health a Buy or a Sell?

  • Astrana Health stock is rated a Sell
    The current Astrana Health [ASTH] share price is $30.5400. The Score for ASTH is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.